Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ce Wu

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Experimental Eye Research|September 16, 2024
Permeation characteristics and cross-linking efficacy of iontophoresis-assisted riboflavin delivery for accelerated riboflavin-ultraviolet A scleral collagen cross-linking in porcine eyesXiaona Liu, Lingling Yan, Junchao Wei, et al.
Translational Vision Science & Technology|March 4, 2025
Evaluation of the Long-Term Corneal Biomechanics Following SMILE With Different Residual Stromal Bed Thickness in RabbitsHongwei Qin, Xin Yang, Rui He, et al.
International Immunopharmacology|May 13, 2022
Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapyYan-Xin Niu, Zhao-Xu Xu, Li-Feng Yu, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Experimental Eye Research|September 16, 2024
Permeation characteristics and cross-linking efficacy of iontophoresis-assisted riboflavin delivery for accelerated riboflavin-ultraviolet A scleral collagen cross-linking in porcine eyesXiaona Liu, Lingling Yan, Junchao Wei, et al.
Translational Vision Science & Technology|March 4, 2025
Evaluation of the Long-Term Corneal Biomechanics Following SMILE With Different Residual Stromal Bed Thickness in RabbitsHongwei Qin, Xin Yang, Rui He, et al.
International Immunopharmacology|May 13, 2022
Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapyYan-Xin Niu, Zhao-Xu Xu, Li-Feng Yu, et al.
Pageof 3